EBAC

COM:LSPVC

EQT Life Sciences

Stock

Last Close

11.71

02/03 21:00

Market Cap

183.50M

Beta: -

Volume Today

77.64K

Avg: -

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Mar '21	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22	Sep '22	Dec '22
net income	254.84K -	473.52K 85.81%	233.61K 50.67%	750.31K 221.18%	1.51M 101.37%	200.69K 86.72%	-400.02K 299.33%	-968.67K 142.15%
depreciation and amortization
deferred income tax
stock based compensation
change in working capital	69.80K -	-137.32K 296.75%	119.56K 187.06%	333.97K 179.34%	113.28K 66.08%	-37.82K 133.39%	979.80K 2,690.84%	1.25M 27.36%
accounts receivables
inventory
accounts payables	305.30K -	-223.80K 173.30%	152K 167.92%	129.70K 14.67%	321.16K 147.62%	-247.78K 177.15%	81.54K 132.91%	146.71K 79.92%
other working capital	-235.50K -	86.47K 136.72%	-32.44K 137.52%	204.27K 729.66%	-207.89K 201.77%	209.97K 201.00%	898.26K 327.81%	1.10M 22.59%
other non cash items	-339.69K -	-668.33K 96.75%	-834.13K 24.81%	-960.02K 15.09%	-1.77M 84.81%	-573.05K 67.70%	-615.26K 7.36%	-198.36K 67.76%
net cash provided by operating activities	-15.05K -	-332.13K 2,106.12%	-480.96K 44.81%	124.27K 125.84%	-149.99K 220.70%	-410.19K 173.48%	-35.47K 91.35%	80.86K 327.94%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites	-120M -	-7.55M 93.71%	-127.55M 1,589.86%	255.10M 300%
net cash used for investing activites	-120M -	-7.55M 93.71%	-127.55M 1,589.86%	255.10M 300%
debt repayment	-37.81K -			-37.81K -
common stock issued	124.40M -	7.69M 93.82%		-132.09M -
common stock repurchased
dividends paid
other financing activites	-2.74M -	-169.11K 93.83%	129.10M 76,443.32%	-126.12M 197.69%				-45K -
net cash used provided by financing activities	121.62M -	7.52M 93.81%	129.10M 1,615.94%	-258.25M 300.03%				-45K -
effect of forex changes on cash	120.02M -		-1.25M -	2.82M 325.78%
net change in cash	121.62M -	-356.13K 100.29%	-173.78K 51.20%	-207.87K 19.62%	-149.99K 27.84%	-410.19K 173.48%	-35.47K 91.35%	35.86K 201.09%
cash at beginning of period	-120.02M -	1.61M 101.34%	1.25M 22.17%	1.08M 13.90%	868.28K 19.32%	718.29K 17.27%	308.10K 57.11%	272.63K 11.51%
cash at end of period	1.61M -	1.25M 22.17%	1.08M 13.90%	868.28K 19.32%	718.29K 17.27%	308.10K 57.11%	272.63K 11.51%	308.49K 13.15%
operating cash flow	-15.05K -	-332.13K 2,106.12%	-480.96K 44.81%	124.27K 125.84%	-149.99K 220.70%	-410.19K 173.48%	-35.47K 91.35%	80.86K 327.94%
capital expenditure
free cash flow	-15.05K -	-332.13K 2,106.12%	-480.96K 44.81%	124.27K 125.84%	-149.99K 220.70%	-410.19K 173.48%	-35.47K 91.35%	80.86K 327.94%

All numbers in (except ratios and percentages)